Literature DB >> 9538626

Effects of levosulpiride in patients with functional dyspepsia accompanied by delayed gastric emptying.

C W Song1, H J Chun, C D Kim, H S Ryu, J G Choe, J H Hyun.   

Abstract

OBJECTIVES: Levosulpiride is the levo-enantiomer of sulpiride, a well-known antiemetic, antidyspeptic and antipsychotic drug. This study was undertaken to investigate the effects of levosulpiride on dyspeptic symptoms and gastric motor function in a group of patients with functional dyspepsia showing delayed gastric emptying.
METHOD: Forty two eligible patients were entered into a 3 week, double-blind randomized comparison of 25mg of levosulpiride or placebo t.i.d.. Symptom assessment and gastric scintigraphy following the intake of scrambled egg sandwich, were performed in each patient before and after treatment.
RESULTS: The improvement of symptom score in levosulpiride group was higher than the placebo group (p < 0.05). We assessed global efficacy, which was excellent in 1 (6%), good 11 (65%), fair 4 (24%), nil 1 (6%) of those receiving levosulpiride, and fair 9 (60%), nil 5 (33%), poor 1 (6%) of those receiving placebo. Levosulpiride tended to be more effective than placebo in relieving the dyspeptic symptoms especially in the subgroups of dysmotility-like (p < 0.05) and nonspecific (p < 0.05) as compared to other subgroups (p = 0.16). The reduction of gastric emptying time after levosulpiride treatment was more marked than Placebo group (p < 0.05). We found a significant correlation between changes of symptom score and gastric emptying time (r = 0.47, p = 0.01). No serious adverse effects were reported after administration of either levosulpiride or placebo. Only two patients reported mild somnolence during levosulpiride administration.
CONCLUSIONS: Levosulpiride is effective and well tolerated in patients with functional dyspepsia accompanied by delayed gastric emptying. Its efficacy may be related to its action on the gastric motor function by improving the delayed gastric emptying.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9538626      PMCID: PMC4531935          DOI: 10.3904/kjim.1998.13.1.15

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  6 in total

Review 1.  New antipsychotics: classification, efficacy, and adverse effects.

Authors:  J Gerlach
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

2.  Frequency of idiopathic gastric stasis and intestinal transit disorders in essential dyspepsia.

Authors:  M Wegener; G Börsch; J Schaffstein; C Reuter; F Leverkus
Journal:  J Clin Gastroenterol       Date:  1989-04       Impact factor: 3.062

3.  Prolactin response to low dose sulpiride.

Authors:  M E McMurdo; P W Howie; M Lewis; M Marnie; J McEwen; A S McNeilly
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

4.  Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis.

Authors:  R Corinaldesi; V Stanghellini; C Raiti; E Rea; R Salgemini; L Barbara
Journal:  Gut       Date:  1987-03       Impact factor: 23.059

5.  Clinical evaluation of domperidone in the treatment of chronic postprandial idiopathic upper gastrointestinal distress.

Authors:  J Nagler; P Miskovitz
Journal:  Am J Gastroenterol       Date:  1981-12       Impact factor: 10.864

6.  Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride.

Authors:  R Jian; F Ducrot; A Ruskone; S Chaussade; J C Rambaud; R Modigliani; J D Rain; J J Bernier
Journal:  Dig Dis Sci       Date:  1989-05       Impact factor: 3.199

  6 in total
  6 in total

Review 1.  New developments in the treatment of functional dyspepsia.

Authors:  Vincenzo Stanghellini; Fabrizio De Ponti; Roberto De Giorgio; Giovanni Barbara; Cesare Tosetti; Roberto Corinaldesi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Efficacy and tolerability of levosulipride, domperidone and metoclopramide in patients with non-ulcer functional dyspepsia: a comparative analysis.

Authors:  Harminder Singh; Ritu Bala; Kamalpreet Kaur
Journal:  J Clin Diagn Res       Date:  2015-04-01

3.  Comparative Efficacy of Various Pharmacological Interventions in the Treatment of Functional Dyspepsia: A Network Meta-Analysis.

Authors:  Liang Liang; Jia Yu; Ling Xiao; Gaohua Wang
Journal:  Dig Dis Sci       Date:  2021-02-15       Impact factor: 3.199

4.  Comparative efficacy and acceptability of psychotropic drugs for functional dyspepsia in adults: A systematic review and network meta-analysis.

Authors:  Wan Zhou; Xia Li; Yin Huang; Xiaoxiao Xu; Yan Liu; Jiayan Wang; Gang Nie; Dongdong Zhou
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

Review 5.  Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review.

Authors:  Mariko Hojo; Hiroto Miwa; Tetsuji Yokoyama; Toshifumi Ohkusa; Akihito Nagahara; Masato Kawabe; Daisuke Asaoka; Yuko Izumi; Nobuhiro Sato
Journal:  J Gastroenterol       Date:  2005-11       Impact factor: 6.772

Review 6.  A Systematic Review of the Effectiveness of Antianxiety and Antidepressive Agents for Functional Dyspepsia.

Authors:  Mariko Hojo; Akihito Nagahara; Daisuke Asaoka; Yuji Shimada; Hitoshi Sasaki; Kohei Matsumoto; Tsutomu Takeda; Hiroya Ueyama; Kenshi Matsumoto; Sumio Watanabe
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.